adv
influenza
viru
ifv
parainfluenza
viru
pifv
respiratori
syncyti
viru
rsv
identifi
signific
pathogen
communityacquir
nosocomi
respiratori
infect
recent
respiratori
viral
infect
caus
ifv
enteroviru
env
adv
may
benefit
specif
antivir
treatment
aim
studi
evalu
suggest
clinic
use
two
kind
multiplex
pcr
identifi
caus
virus
pediatr
viral
pneumonia
sever
lower
respiratori
infect
children
nasopharyng
aspir
pediatr
patient
period
month
obtain
mucu
extractor
sewoon
innovis
medic
seoul
korea
transfer
vial
univers
transport
medium
diagnost
hybrid
inc
athen
oh
usa
pediatr
patient
admit
symptom
sever
lower
respiratori
infect
definit
case
moder
sever
lower
respiratori
infect
determin
accord
world
health
organ
recommend
surveil
standard
edit
lower
respiratori
viral
infect
diagnos
expert
pediatrician
physic
examin
chest
xray
blood
test
erythrocyt
sediment
rate
esr
creactiv
protein
crp
exclud
bacteri
origin
aspir
sampl
immedi
made
aliquot
store
nucleic
acid
extract
viral
cultur
sequenc
analysi
proceed
patient
sampl
collect
accord
protocol
institut
review
board
yonsei
univers
health
system
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
autom
qiacub
qiagen
use
extract
nucleic
acid
nucleic
acid
extract
kept
deep
freezer
analysi
seeplex
tm
rv
detect
kit
http
wwwseegenecokrenindexphp
nucleic
acid
extract
nasopharyng
aspir
use
synthesi
firststrand
cdna
moloney
murin
leukemia
viru
revers
transcriptas
promega
madison
wi
usa
seeplex
tm
rv
detect
kit
cosmo
genetech
seoul
korea
contain
b
set
primer
design
highli
conserv
region
genet
sequenc
respiratori
virus
seeplex
tm
kit
design
identifi
adv
human
metapneumoviru
hmpv
human
coronaviru
hcov
parainfluenza
viru
pifv
pifv
pifv
seeplex
tm
rv
detect
kit
b
design
detect
ifv
ifv
b
rsv
rsv
b
rhinoviru
rhv
hcov
pcr
conduct
final
reaction
volum
contain
cdna
mop
solut
primer
mix
pcr
protocol
sec
follow
cycl
min
min
follow
min
final
extens
amplifi
product
separ
agaros
gel
stain
ethidium
bromid
run
includ
molecular
size
marker
intern
control
also
american
type
cultur
collect
atcc
standard
virus
use
posit
control
distil
water
neg
control
labopass
tm
rv
detect
kit
http
nucleic
acid
nasopharyng
aspir
also
use
labopass
tm
kit
kit
also
design
detect
type
virus
final
reaction
volum
compos
premixtur
nucleic
acid
two
kind
pcr
protocol
use
adv
human
bocaviru
hbov
oper
min
cycl
min
min
min
follow
min
final
extens
preserv
hcov
env
pifv
rhv
rsv
oper
min
min
cycl
min
min
min
follow
min
final
extens
preserv
pcr
product
analyz
identifi
band
agaros
gel
stain
ethidium
bromid
sampl
show
posit
result
adv
ifv
pifv
rsv
two
multiplex
pcr
kit
perform
shell
vial
cultur
rmix
readycel
diagnost
hybrid
inc
athen
oh
usa
accord
manufactur
procedur
firstli
cryopreserv
rmix
cell
reagent
heat
heat
block
min
rins
rins
buffer
remain
min
room
temperatur
meantim
refe
medium
ml
rmix
readycel
mix
specimen
inocul
rmix
readycel
centrifug
min
room
temperatur
overnight
incub
incub
cell
monolay
shell
vial
wash
fix
aceton
stain
respiratori
viru
fluoresc
antibodi
dfa
diagnost
hybrid
inc
athen
oh
usa
virusspecif
fluoresc
note
screen
viru
identif
perform
use
individu
monoclon
antibodi
stain
ifv
b
adv
pifv
rsv
initi
screen
neg
vial
reexamin
day
day
ten
sampl
cultur
neg
multiplex
pcr
posit
proceed
sequenc
analysi
identifi
equivoc
result
sequenc
analys
proceed
repeat
pcr
proper
primer
prepar
specif
virus
identif
autom
sequenc
analyz
appli
biosystem
foster
citi
ca
usa
accompani
recommend
reagent
use
accord
manufactur
protocol
final
result
sequenc
analyz
match
genbank
data
use
basic
local
align
search
tool
blast
http
blastncbinlmnihgovblastcgi
basic
characterist
major
result
pediatr
patient
summar
tabl
posit
rate
seeplex
tm
rv
detect
kit
posit
samplestot
sampl
seeplex
tm
identifi
virus
sum
adv
n
hcov
n
hcov
n
ifv
n
ifv
b
n
hmpv
n
pifv
n
pifv
n
pifv
n
rhv
ab
n
rsv
n
rsv
b
n
labopass
tm
rv
detect
kit
show
posit
posit
samplestot
sampl
labopass
tm
rv
detect
kit
identifi
virus
sum
adv
n
hbov
n
hcov
n
hcov
n
ev
n
ifv
n
ifv
b
n
hmpv
n
pifv
n
pifv
n
pifv
n
rhv
ab
n
rsv
n
coinfect
viru
speci
identifi
rate
seeplex
tm
rv
kit
labopass
tm
rv
kit
one
virus
identifi
multiplex
pcr
rmix
readycel
cultur
proceed
direct
immunofluoresc
stain
sampl
show
posit
multiplex
pcr
adv
ifv
pifv
rsv
shell
vial
cultur
assay
show
posit
sampl
total
sampl
posit
rate
two
sampl
show
kind
virus
total
posit
number
rmix
cultur
note
adv
ifv
ifv
b
pifv
rsv
posit
viral
cultur
rate
seeplex
tm
rv
detect
kit
sampl
total
sampl
labopass
tm
rv
detect
kit
sampl
total
sampl
fifti
sampl
total
sampl
show
result
two
kind
multiplex
pcr
viral
cultur
howev
sampl
show
discrep
result
test
result
divid
group
accord
discrep
charact
tabl
rmix
cultur
use
studi
target
four
virus
adv
ifv
pifv
rsv
virus
could
isol
posit
result
multiplex
pcr
rmix
cultur
detect
adv
ifv
pifv
rsv
compar
fig
sequenc
result
multiplex
pcr
posit
viral
cultur
neg
sampl
ten
sampl
cultur
neg
multiplex
pcr
posit
analyz
sequenc
result
show
tabl
correspond
virus
identifi
homolog
ten
sequenc
result
nine
consist
multiplex
pcr
result
one
complet
discrep
result
multiplex
pcr
sequenc
analysi
case
ifv
versu
rhv
tabl
pneumonia
pediatr
patient
essenti
prevent
diseas
propag
also
help
earli
initi
proper
manag
earli
start
proper
antivir
manag
reduc
unnecessari
overus
antibacteri
agent
addit
respiratori
virus
includ
ifv
env
adv
may
benefit
specif
antivir
treatment
commonli
use
method
identifi
respiratori
virus
enzym
immunoassay
may
quicker
less
sensit
convent
method
may
affect
specimen
qualiti
viru
type
technic
skill
viru
cultur
still
consid
gold
standard
respiratori
viru
detect
limit
turnaround
time
specimen
transport
storag
condit
maintain
infect
viru
compar
test
method
choi
et
al
report
posit
rate
direct
antigen
test
viral
cultur
method
multiplex
pcr
detect
adv
ifv
pifv
rsv
respect
recent
viru
identif
immunosta
shell
vial
cultur
wide
accept
laboratori
standard
method
viru
test
method
still
easi
routin
test
clinic
laboratori
nucleic
acid
amplif
method
includ
multiplex
pcr
power
altern
limit
fals
posit
fals
neg
nucleic
acid
amplif
test
faster
cultur
method
report
sensit
autom
day
addit
advantag
detect
virus
grow
poorli
cell
cultur
hmpv
korean
nation
survey
respiratori
viru
test
perform
thirtyon
clinic
laboratori
respond
provid
respiratori
viru
test
clinic
diagnosi
korea
among
respond
pcr
andor
cultur
wide
adopt
institut
rapid
immunochromatograph
method
immunofluoresc
antigen
assay
enzym
immunoassay
focus
four
major
respiratori
virus
adv
ifv
pifv
rsv
exact
concord
rate
two
kind
multiplex
pcr
rmix
viral
cultur
result
two
multiplex
pcr
show
equival
higher
posit
rate
studi
two
kind
multiplex
pcr
reagent
show
differ
posit
accord
viru
type
posit
rate
seeplex
tm
rv
detect
kit
higher
labopass
tm
rv
kit
ifv
rhv
howev
identif
pediatr
respiratori
viru
labopass
tm
rv
kit
detect
hmpv
seeplex
tm
rv
kit
discrep
result
two
type
multiplex
pcr
rmix
cultur
compris
total
weinberg
et
al
report
pcr
method
could
detect
virus
two
time
compar
viru
cultur
studi
show
concord
rate
seeplex
pcr
viru
cultur
labopass
pcr
result
similar
previou
report
discrep
might
caus
multiplex
pcr
limit
one
major
limit
pcr
detect
falseneg
result
consequ
pcr
inhibitor
present
clinic
sampl
remov
extract
process
anoth
limit
principl
pcr
could
produc
fals
result
primer
region
nucleotid
variat
unabl
detect
new
type
strain
viru
reason
direct
antigen
test
viru
cultur
complet
substitut
solitari
multiplex
pcr
test
notic
coinfect
rate
viru
type
identifi
seeplex
tm
rv
kit
labopass
tm
rv
kit
previou
studi
suggest
doubleviru
infect
associ
greater
sever
respiratori
tract
infect
studi
could
find
remark
paramet
differ
clinic
sever
case
coinfect
ten
case
cultur
neg
multiplex
pcr
posit
evalu
direct
sequenc
studi
sequenc
result
confirm
almost
origin
result
multiplex
pcr
conclus
identif
respiratori
virus
multiplex
pcr
rapid
easier
method
show
posit
result
viral
cultur
method
henc
multiplex
pcr
first
choic
detect
respiratori
virus
clinic
laboratori
complementari
effort
viral
cultur
sequenc
method
could
select
proceed
select
case
accord
laboratori
environ
